Drugs / autologous CD4-positive antigen-specific T cells
autologous CD4-positive antigen-specific T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00101257 | Oct 2004 → Mar 2010 | ovarian carcinoma, peritoneum cancer | Fred Hutchinson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous CD4-positive antigen-specific T cells | “Patients receive autologous CD4-positive antigen-specific T cells IV over 30 minutes.” NCT00101257 ↗ |
| Modality | Cell therapy | “cellular adoptive immunotherapy” NCT00101257 ↗ |
| Route | Intravenous | “Patients receive autologous CD4-positive antigen-specific T cells IV over 30 minutes.” NCT00101257 ↗ |